UCB Canada

UCB Canada is owned by UCB.

UCB is one of the...

• Forbes Global 2000 (#1750);
• Fortune 500 Europe (#486);
• Stoxx 600.

UCB is a company listed under the stock ticker UCB (BE).

UCB has a direct presence in 10 countries.

UCB has 10 subsidiaries including UCB Australia, UCB Canada and UCB France.

They are in:

• Pharmaceuticals91%
• Fund9%

View the org chart displaying its 1 main executives

Most searched biographies at UCB Canada

• Lionel Houle, Business Unit Director, Immunology

Create your alert
to follow the executive moves at UCB Canada.

UCB has 1,868 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by UCB Canada

Social media about UCB Canada

• UCB Canada on Wikipedia, Google News & Yahoo Finance
• UCB Canada on LinkedIn, Twitter & YouTube

Contact by email its executives including Lionel Houle

Call UCB Canada at +1 905...

View the org chart

Register to receive your alert

Report an error